News
April 15, 2025--(BUSINESS WIRE)--Imperative Care, Inc. today announced it will ... trial comparing aspiration thrombectomy with the Zoom Stroke System plus best medical treatment versus best ...
Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, has announced the appointment of Daniel Davis to its Board of ...
The Zoom comprehensive stroke thrombectomy system large-bore .088-in. catheters. [Image courtesy of Imperative Care] Imperative Care announced today that it intends to fund a trial comparing its ...
April 15, 2025—Imperative Care, Inc. announced it will fund an investigator-initiated, multicenter, randomized controlled trial (RCT) comparing aspiration thrombectomy using the company’s Zoom stroke ...
Investigator-initiated trial to compare aspiration thrombectomy with the Zoom Stroke System plus best medical treatment versus best medical treatment alone for M2 vessel occlusions CAMPBELL, ...
Ophthalmologists reflect on the transformative impact of COVID-19, highlighting adaptations in patient care, safety protocols ...
Measles have been in the news over the past few months due to outbreaks in Texas and other states. The Centers for Disease ...
He does not care — he will not even seek to discover ... to make it easier for this person to return. But I think to Zoom out, this is by design in all of these contexts, whether it ...
The telecom giant is long gone, of course, but its impact is still being felt. An oral history of what it was like to be on Canada’s ‘rocket ship’ ...
17d
Axios on MSNTallying chatbots' true carbon costsAI's carbon footprint remains a riddle three years into the genAI revolution, thanks to AI makers' secrecy and the difficulty of accurate measurements at scale. Why it matters: Chatbot users say ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results